Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Nonlinear Dyn ; 111(5): 4915-4929, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36373036

RESUMO

Nowadays, the mathematical modeling of infectious diseases is a big trend worldwide. The mathematical models help us to forecast future outbreaks of diseases in the presence of present data. In this article, we represent a model of the transmission of Chlamydia in the United States by using data from 1989 to 2019. In the formulation of the model, we used integer and fractional derivatives. Several graphs are plotted for the various possible cases of the given parameters. The aim of this paper is to justify how the mathematical models in terms of fractional derivatives have more degree of freedom to explore disease dynamics for a particular data set and capture memory effects. The separate parameter estimation for each value of the fractional order increases the novelty of this work. The use of a real-data set of Chlamydia in the United States makes this study more visible and important to the literature.

2.
Adv Contin Discret Model ; 2022(1): 11, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35450199

RESUMO

We analyze a time-delay Caputo-type fractional mathematical model containing the infection rate of Beddington-DeAngelis functional response to study the structure of a vector-borne plant epidemic. We prove the unique global solution existence for the given delay mathematical model by using fixed point results. We use the Adams-Bashforth-Moulton P-C algorithm for solving the given dynamical model. We give a number of graphical interpretations of the proposed solution. A number of novel results are demonstrated from the given practical and theoretical observations. By using 3-D plots we observe the variations in the flatness of our plots when the fractional order varies. The role of time delay on the proposed plant disease dynamics and the effects of infection rate in the population of susceptible and infectious classes are investigated. The main motivation of this research study is examining the dynamics of the vector-borne epidemic in the sense of fractional derivatives under memory effects. This study is an example of how the fractional derivatives are useful in plant epidemiology. The application of Caputo derivative with equal dimensionality includes the memory in the model, which is the main novelty of this study.

3.
Adv Contin Discret Model ; 2022(1): 31, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35450200

RESUMO

Study of ecosystems has always been an interesting topic in the view of real-world dynamics. In this paper, we propose a fractional-order nonlinear mathematical model to describe the prelude of deteriorating quality of water cause of greenhouse gases on the population of aquatic animals. In the proposed system, we recall that greenhouse gases raise the temperature of water, and because of this reason, the dissolved oxygen level goes down, and also the rate of circulation of disintegrated oxygen by the aquatic animals rises, which causes a decrement in the density of aquatic species. We use a generalized form of the Caputo fractional derivative to describe the dynamics of the proposed problem. We also investigate equilibrium points of the given fractional-order model and discuss the asymptotic stability of the equilibria of the proposed autonomous model. We recall some important results to prove the existence of a unique solution of the model. For finding the numerical solution of the established fractional-order system, we apply a generalized predictor-corrector technique in the sense of proposed derivative and also justify the stability of the method. To express the novelty of the simulated results, we perform a number of graphs at various fractional-order cases. The given study is fully novel and useful for understanding the proposed real-world phenomena.

4.
J Postgrad Med ; 68(2): 102-105, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35466662

RESUMO

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was admitted for left pyopneumothorax. He was started on intravenous piperacillin-tazobactam (Pip/Taz) and clindamycin. After 10 days of treatment, he developed high grade fever with maculopapular rashes with areas of scaling. He had elevated WBC counts with eosinophils of 21% and raised serum transaminases. After excluding other possible etiologies for febrile illness, a possibility of DRESS was considered. Naranjo scale, used for causality assessment, yielded a total score of 6, pointing toward probable adverse drug reaction. Also, the patient had 6 out of the 7 inclusion criteria for DRESS as per European Registry of Severe Cutaneous Adverse Reaction (RegiScar) scoring. Pip/Taz was found to be causative drug and was discontinued. He was conservatively managed with antipyretics and topical steroids. Fever subsided the day after stopping Pip/Taz and his rashes resolved gradually. In conclusion the possibility of antibiotics-induced DRESS should be considered and high index of vigilance is advised.


Assuntos
Síndrome de Hipersensibilidade a Medicamentos , Eosinofilia , Exantema , Antibacterianos/efeitos adversos , Síndrome de Hipersensibilidade a Medicamentos/diagnóstico , Síndrome de Hipersensibilidade a Medicamentos/etiologia , Eosinofilia/induzido quimicamente , Exantema/induzido quimicamente , Febre/induzido quimicamente , Humanos , Masculino , Pessoa de Meia-Idade , Piperacilina/efeitos adversos , Tazobactam/efeitos adversos
5.
Cochrane Database Syst Rev ; 5: CD009903, 2019 05 31.
Artigo em Inglês | MEDLINE | ID: mdl-31150100

RESUMO

BACKGROUND: Multiple sclerosis (MS) is a leading cause of neurological disability in young adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an immune-mediated disease. It has been hypothesised that intraluminal defects, compression, or hypoplasia in the internal jugular or azygos veins may be important factors in the pathogenesis of MS. This condition has been named 'chronic cerebrospinal venous insufficiency' (CCSVI). It has been suggested that these intraluminal defects restrict the normal blood flow from the brain and spinal cord, causing the deposition of iron in the brain and the eventual triggering of an auto-immune response. The proposed treatment for CCSVI is venous percutaneous transluminal angioplasty (PTA), which is claimed to improve the blood flow in the brain thereby alleviating some of the symptoms of MS. This is an update of a review first published in 2012. OBJECTIVES: To assess the benefit and safety of venous PTA in people with MS and CCSVI. SEARCH METHODS: We searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group's Specialised Register up to 30 August 2018, CENTRAL (in the Cochrane Library 2018, issue 8), MEDLINE up to 30 August 2018, Embase up to 30 August 2018, metaRegister of Controlled Trials, ClinicalTrials.gov., the Australian New Zealand Clinical Trials Registry, and the World Health Organization (WHO) International Clinical Trials Registry platform. We examined the bibliographies of the included and excluded studies. SELECTION CRITERIA: We included randomised controlled trials (RCTs) in which PTA and sham interventions were compared in adults with MS and CCSVI. DATA COLLECTION AND ANALYSIS: Two authors independently assessed study eligibility and risk of bias, and extracted data. We reported results as risk ratios (RR) with 95% confidence intervals (CI). We performed statistical analyses using the random-effects model; and we assessed the certainty of the evidence using GRADE. MAIN RESULTS: We included three RCTs (238 participants) in this update. One hundred and thirty-four participants were randomised to PTA and 104 to sham treatment. We attributed low risk of bias to two (67%) studies for sequence generation and two (67%) studies for performance bias. All studies were at a low risk of detection bias, attrition bias, reporting bias and other potential sources of bias.There was moderate-quality evidence to suggest that venous PTA did not increase the proportion of patients who had operative or post-operative serious adverse events compared with the sham procedure (RR 3.33, 95% CI 0.36 to 30.44; 3 studies, 238 participants); nor did it increase the proportion of patients who improved on a functional composite measure including walking control, balance, manual dexterity, postvoid residual urine volume, and visual acuity over 12-month follow-up (RR 0.84, 95% CI 0.55 to 1.30; 1 study, 110 participants); nor did it reduce the proportion of patients who experienced new relapses at six- or 12-month follow-up (RR 0.87, 95% CI 0.51 to 1.49; 3 studies, 235 participants). There was no effect of venous PTA on disability worsening measured by the Expanded Disability Status Scale, which was reported at follow-up intervals of six months (one study), 11 months (one study) and 12 months (one study). Quality of life was reported in two studies with no difference between treatment groups. Moderate or severe pain during or post venography was reported in both PTA and sham-procedure participants in all included studies. Venous PTA was not effective in restoring blood flow assessed at one-month (one study) or 12-month follow-up (one study). AUTHORS' CONCLUSIONS: This systematic review identified moderate-quality evidence that, compared with sham procedure, venous PTA intervention did not provide benefit on patient-centred outcomes (disability, physical or cognitive functions, relapses, quality of life) in people with MS. Venous PTA has proven to be a safe technique but in view of the available evidence of its ineffectiveness, this intervention cannot be recommended in people with MS. All ongoing trials were withdrawn or terminated and hence this updated review is conclusive. No further randomised clinical studies are needed.


Assuntos
Angioplastia/métodos , Circulação Cerebrovascular/fisiologia , Esclerose Múltipla/complicações , Insuficiência Venosa/cirurgia , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Insuficiência Venosa/etiologia
6.
Oman Med J ; 34(3): 184-193, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31110624

RESUMO

OBJECTIVES: In 2017, the World Health Organization (WHO) published a list of global priority pathogens (GPP) - 12 species of bacteria with critical, high, and medium antibiotic resistance (AR). In this review, our goal was to quantify published reports of AR in this group of pathogens using the Medline-PubMed databases. We also sought to quantify, compare and rank the top five reported AR pathogens globally, regionally and for Bahrain, and describe the evidence from Bahrain for the purpose of infection prevention and control, and to help research and development. METHODS: We conducted a bibliometric, retrospective, descriptive review to search the Medline-PubMed database for reports specific to the WHO GPP list published up to 19 April 2017. RESULTS: Our search revealed 42 136 documents with an increase in the last five years. Globally, there were more high tier pathogen documents (33 640) than critical (6405) and medium (2091). Methicillin-resistant Staphylococcus aureus (MRSA) was the highest reported, followed by extended-spectrum beta-lactamases (ESBL) resistant Enterobacteriaceae and vancomycin-resistant Enterococcus faecium. Nine out of the 12 pathogens were gram-negative. MRSA was the topmost documented pathogen globally and in the Gulf Cooperation Council (GCC) region zone of classification, whereas ESBL resistant Enterobacteriaceae ranked the top in Bahrain. There were two critical tier pathogens in the global, GCC region, and Bahrain. We found 14 articles from Bahrain, four articles on ESBL resistant Enterobacteriaceae, three on MRSA, two on carbapenem-resistant Acinetobacter baumannii, and five on different pathogens. CONCLUSIONS: Our findings suggest the need for a comprehensive, multipronged policy response particularly at the time when the antibiotic pipeline is nearly empty. We recommend thoughtful, integrated infection prevention and control strategies to address the immediate and long-term threats of AR in Bahrain and the GCC.

7.
J Postgrad Med ; 63(4): 262-264, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28862244

RESUMO

Unilateral absence of pulmonary artery or pulmonary artery agenesis (UAPA) is a rare congenital malformation that can present as an isolated lesion or in association with other cardiac anomalies. Though congenital, presentation in adults are also reported. Most common presentation in adults is of exercise intolerance. The developing lung on the affected side is hypoplastic. Diagnosis of UAPA is established by imaging methods like CT and MRI . There is no specific treatment for this condition. Treatment depends on patients symptomatology, presence of pulmonary hypertension and collateral circulation. Presence of pulmonary hypertension carries a bad prognosis. We present two adult patients with isolated left sided unilateral pulmonary artery agenesis with ipsilateral lung hypoplasia. The diagnosis was confirmed by CT chest and perfusion scan.


Assuntos
Anormalidades Múltiplas/diagnóstico por imagem , Dispneia/etiologia , Pneumopatias/diagnóstico por imagem , Pulmão/anormalidades , Artéria Pulmonar/anormalidades , Artéria Pulmonar/diagnóstico por imagem , Adulto , Idoso , Bronquiectasia/diagnóstico por imagem , Bronquiectasia/etiologia , Broncoscopia , Feminino , Humanos , Pulmão/diagnóstico por imagem , Imageamento por Ressonância Magnética , Artéria Pulmonar/patologia , Infecções Respiratórias/etiologia , Tomografia Computadorizada por Raios X
8.
Cent Asian J Glob Health ; 4(1): 139, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-29138713

RESUMO

INTRODUCTION: Zoonotic disease outbreaks have surged in the last two decades. These include severe acute respiratory syndrome (SARS), Hendra virus, Nipah virus, influenza viruses, Middle East Respiratory Syndrome (MERS) coronavirus, and ebola. One Health is the initiative of an inclusive collaboration linking human, animal, and environmental health. One Health is advocated through an intersectoral coordination to combat zoonoses, and the term has evolved over centuries. The primary aim of this literature review was to examine the change in the definition of the term One Health over time, particuarly following the the introduction of the latest definition in 2007 by the American Medical Association and the American Veterinary Medical Association. METHODS: This review was conducted in four phases. The first phase consisted of a general PubMed search for the phrase "One Health" for every literature published up to December 2014. Then an advanced search was carried out using "One Health" in conjunction with the terms "zoonosis" and "zoonoses" in PubMed for the time period between January 2007 and December 2014. The articles found were then categorized based on the type of journals in which the articles were published. For the second phase, "One Health" was searched as a Medical subject heading (MeSH) term, which is the National Library of Medicine controlled vocabulary thesaurus used for indexing articles. In the third phase, One Health advocate organizations were found using Google search engine. During the final phase, One Health was searched in Google scholar, examined by Google trends, and analyzed by Google ngram. RESULTS: Before 2007, One Health had many connotations to health in the medical literature with an incomplete adherence to the usage of One Health linking zoonoses. The Google trends analysis shows an overal steady increase of the search of One Health from 2007 to 2014, which is consistent with the findings of articles from Pubmed. DISCUSSION: Our results indicate that the linkage between the terms One Health and zoonoses started in 2007, which correlates with the joint declaration made by the American Medical Association and the American Veterinary Medical Association in 2007. We suggest creating a MeSH term for One Health in the PubMed database to support more specific research on zoonoses, and exploring the possibility of a patent of the term One Health to support global health and evidence based public health.

9.
Parasitol Res ; 112(6): 2353-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23525692

RESUMO

Diethylcarbamazine (DEC) interferes with arachidonic acid metabolism for the clearance of microfilariae in Wuchereria bancrofti infected individuals. In this study, we have quantified the plasma concentrations of prostaglandin E2 (PGE2) and 6-keto-PGF1α, the end products of arachidonic acid metabolic pathway in microfilaraemics (DEC treated and untreated), and normal healthy individuals at pre- and 3,9,12,36, and 72 h of post-DEC treatment. We have also determined the microfilariae counts at pre and post day 2 (36 h) and day 3 (72 h) of DEC treatment by membrane filtration technique. Significant reduction in PGE2 and 6-keto-PGF1α concentrations was found at 12 h of DEC treatment. Rapid reduction in microfilarial counts was observed at 36 h of post-DEC treatment. Higher levels of prostaglandins were found at pre-treatment hours in microfilaraemics compared to normal healthy individuals (P < 0.05). Our findings indicate that DEC inhibits prostaglandins for the clearance of microfilariae, and increased levels of prostaglandins in microfilaraemics may be contributed by the parasite or host upon stimulation.


Assuntos
6-Cetoprostaglandina F1 alfa/sangue , Dietilcarbamazina/administração & dosagem , Dinoprostona/sangue , Filariose Linfática/tratamento farmacológico , Filaricidas/administração & dosagem , Wuchereria bancrofti/isolamento & purificação , Animais , Filariose Linfática/parasitologia , Humanos , Parasitemia
10.
Indian J Community Med ; 37(3): 200-1, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23112450
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...